Rising prevalence of fungal infections coupled with an increase in awareness is estimated to stimulate market demand.
Market Size – USD 11.61 billion in 2018, Market Growth - CAGR of 1.4%, Market Trends – Increased investments in R&D for drug discovery
The global antifungal drugs market is expected to reach USD 13.03 Billion by 2026, according to a new report by Reports and Data. Antifungal drugs are used to treat fungal infections. Rising prevalence of fungal infections and fungal diseases is one of the most significant factors anticipated to boost the market demand in the upcoming years. Though most of the infections caused by fungus are non-fatal in nature but cause great inconvenience in the people suffering from it and as a result would require proper medication for their cure.
An increase in the level of disposable income of the people coupled with increasing awareness towards healthy well-being is likely to boost the growth of the market in the future. An increase in the population of people with weak immunity who are vulnerable to fungal infection and an increase in the elderly population are also forecasted to drive the market in the future.
Additionally, increased investments made in R&D along with public-private partnership agreements in the pharmaceutical industry to come up with novel and more effective drug for treating fungal infections as well as the increasing demand for OTC (over-the-counter) antifungal drugs especially for treatment for skin related infection is causative of the growth of the market.
Availability of generic drugs and conventional therapies for fungal infections may create hindrances in the growth of the market in the forecast period.
Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/1399
The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.
Key players in the market include
Merck & Co. Inc., Novartis AG, Pfizer Inc., Bayer AG, Enzon Pharmaceuticals Inc., GlaxoSmithKline PLC, Abbott, Sigma-Aldrich, Glenmark Pharmaceuticals, and Astellas Pharma Inc. among others.
For a better understanding of the global Antifungal Drugs market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.
Request a discount on the report @ https://reportsanddata.com/discount-enquiry-form/1399


Rising prevalence of fungal infections coupled with an increase in awareness is estimated to stimulate market demand. Market Size – USD 11.61 billion in 2018, Market Growth - CAGR of 1.4%, Market Trends – Increased investments in R&D for drug discovery The global antifungal drugs market is expected to reach USD 13.03 Billion by 2026, according to a new report by Reports and Data. Antifungal drugs are used to treat fungal infections. Rising prevalence of fungal infections and fungal diseases is one of the most significant factors anticipated to boost the market demand in the upcoming years. Though most of the infections caused by fungus are non-fatal in nature but cause great inconvenience in the people suffering from it and as a result would require proper medication for their cure. An increase in the level of disposable income of the people coupled with increasing awareness towards healthy well-being is likely to boost the growth of the market in the future. An increase in the population of people with weak immunity who are vulnerable to fungal infection and an increase in the elderly population are also forecasted to drive the market in the future. Additionally, increased investments made in R&D along with public-private partnership agreements in the pharmaceutical industry to come up with novel and more effective drug for treating fungal infections as well as the increasing demand for OTC (over-the-counter) antifungal drugs especially for treatment for skin related infection is causative of the growth of the market. Availability of generic drugs and conventional therapies for fungal infections may create hindrances in the growth of the market in the forecast period. Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/1399 The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances. Key players in the market include Merck & Co. Inc., Novartis AG, Pfizer Inc., Bayer AG, Enzon Pharmaceuticals Inc., GlaxoSmithKline PLC, Abbott, Sigma-Aldrich, Glenmark Pharmaceuticals, and Astellas Pharma Inc. among others. For a better understanding of the global Antifungal Drugs market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region. Request a discount on the report @ https://reportsanddata.com/discount-enquiry-form/1399
REPORTSANDDATA.COM
Antifungal Drugs Market Size 2019 | Demand | Industry Forecast
Antifungal drugs market Key participants include Merck & Co., Novartis AG, Pfizer Inc., Bayer AG, Enzon Pharma Inc., GlaxoSmithKline PLC, Abbott, Sigma-Aldrich, Glenmark Pharma, and Astellas Pharma Inc.
0 Comments 0 Shares
Sponsored